Oslo, Norway, 22 May 2023
Vistin Pharma ASA (OSE: VISTIN): Please find attached the minutes from the Annual General Meeting held today, on the 22 May 2023. All matters were resolved as proposed in the call for the Annual General Meeting.
For further information, please contact:
Alexander Karlsen
CFO
+47 97 05 36 21
alexander.karlsen@vistin.com
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Attachment
CARLSBAD, Calif., May 12, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology…
MENLO PARK, Calif., May 12, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company…
Investment led by Fulcrum Equity Partners to accelerate Olio's mission of transforming care coordination. INDIANAPOLIS,…
POTOMAC, Md., May 12, 2025 /PRNewswire/ -- Z Advanced Computing, Inc. (ZAC), the pioneer Cognitive…
Electronic Health Systems Pioneer Carla Balch Joins Aranscia's Executive Leadership Team HOUSTON, May 12, 2025…
New Survey and Focus Group Series Underscores Parents' Worries About Youth Mental Health and Desire…